scholarly article | Q13442814 |
P2093 | author name string | P. Sève | |
S. Abad | |||
L. Kodjikian | |||
L. Varron | |||
P2860 | cites work | Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop | Q24727581 |
Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion | Q33217011 | ||
Ocular involvement in sarcoidosis | Q33803813 | ||
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation | Q34789015 | ||
Uveitis in sarcoidosis | Q34791280 | ||
Mycophenolate mofetil therapy for sarcoidosis-associated uveitis | Q34991196 | ||
Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients | Q35553908 | ||
Uveitis referral pattern in a Midwest University Eye Center | Q35620179 | ||
Infliximab in chronic ocular inflammation | Q36037311 | ||
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. | Q36388536 | ||
Ocular sarcoidosis in a Korean population | Q37232024 | ||
Causes and frequency of blindness in patients with intraocular inflammatory disease | Q37319691 | ||
A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. | Q37384067 | ||
THE EYES IN SARCOIDOSIS. | Q37401901 | ||
Relapse of sarcoidosis upon treatment with etanercept | Q81262406 | ||
Intermediate uveitis | Q81468638 | ||
Sarcoidosis | Q81468647 | ||
Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab | Q81557916 | ||
Clinical features of intraocular inflammation in Hokkaido, Japan | Q81694731 | ||
[Guidelines for the management of uveitis in internal medicine] | Q82111816 | ||
Favorable response to high-dose infliximab for refractory childhood uveitis | Q82869656 | ||
The role of EBUS-TBNA for the diagnosis of sarcoidosis--comparisons with other bronchoscopic diagnostic modalities | Q84393678 | ||
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases | Q37474072 | ||
International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). | Q37544507 | ||
Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis. | Q37544515 | ||
Sarcoidosis and its ocular manifestations | Q41088529 | ||
Clinical characteristics of patients in a case control study of sarcoidosis | Q44248269 | ||
Sarcoidosis and Its Ophthalmic Manifestations | Q44383894 | ||
Refractory Sarcoidosis Responding to Infliximab * | Q44647059 | ||
Leflunomide for chronic sarcoidosis | Q44884377 | ||
Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab). | Q45075976 | ||
Clinical outcomes in sarcoidosis after cessation of infliximab treatment | Q45169852 | ||
Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients | Q45184183 | ||
Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases | Q45241038 | ||
Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group | Q46047853 | ||
Treatment of sarcoidosis with infliximab | Q46375478 | ||
Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis | Q46549629 | ||
Effectiveness of infliximab in treating selected patients with sarcoidosis | Q46613535 | ||
Clinical and investigative profile of biopsy-proven sarcoid uveitis in India | Q46671381 | ||
The value of endoscopic ultrasound after bronchoscopy to diagnose thoracic sarcoidosis | Q49121190 | ||
Referral patterns of uveitis in a tertiary eye care center. | Q51034605 | ||
Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis? | Q51657028 | ||
Uveitis with biopsy-proven sarcoidosis in Chinese--a study of 60 patients in a uveitis clinic over a period of 20 years. | Q51724861 | ||
Pattern of ocular manifestations in patients with sarcoidosis in developing countries. | Q51744994 | ||
Prognosticators for visual outcome in sarcoid uveitis. | Q52292819 | ||
Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings. | Q53336796 | ||
Sarcoidosis | Q56270542 | ||
The ocular and systemic prognosis of patients presenting with sarcoid uveitis | Q61054138 | ||
Uveitis Subtypes in a German Interdisciplinary Uveitis Center—Analysis of 1916 Patients | Q61446037 | ||
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial | Q63370850 | ||
Course and outcome of ocular sarcoidosis | Q67945312 | ||
Risk factors for ocular sarcoidosis | Q69447579 | ||
Ocular involvement in chronic sarcoidosis | Q69607003 | ||
Endogenous uveitis: an analysis of 1,417 cases | Q71614315 | ||
Cataract surgery in patients with sarcoidosis-associated uveitis | Q72291478 | ||
Peripheral multifocal chorioretinitis: a distinct clinical entity? | Q73886699 | ||
Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients | Q73947310 | ||
Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center | Q74258850 | ||
Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis | Q74598094 | ||
Chest computerized tomography in the evaluation of uveitis in elderly women | Q77876138 | ||
Methotrexate treatment for sarcoid-associated panuveitis | Q77902774 | ||
Sarcoidosis and uveitis | Q78521698 | ||
Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis | Q79174837 | ||
Sarcoid-related uveitis occurring during etanercept therapy | Q79281819 | ||
[Chronic severe uveitis: classification, search for etiology and therapeutic approach] | Q79346016 | ||
Conjunctival biopsy in sarcoidosis | Q79349651 | ||
[Interest of an internist's consultation in uveitis. Comparative study in 66 cases] | Q80049557 | ||
Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients | Q80079822 | ||
Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab | Q80371813 | ||
Association between heat shock protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis | Q80527793 | ||
Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial | Q81059776 | ||
P433 | issue | 2 | |
P407 | language of work or name | French | Q150 |
P921 | main subject | uveitis | Q280027 |
P304 | page(s) | 86-92 | |
P577 | publication date | 2010-10-20 | |
P1433 | published in | Revue de Médecine Interne | Q3428665 |
P478 | volume | 32 |
Q34692643 | Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats |
Q26829826 | Biologics in uveitis |
Q86921897 | Cistoid macular edema as first manifestation of sarcoidosis |
Q35901288 | Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis |
Q53135274 | Ocular sarcoidosis: when should labial salivary gland biopsy be performed? |
Q35554332 | Sarcoidosis in the national veteran population: association of ocular inflammation and mortality |
Q88092201 | [Ocular sarcoidosis] |
Q57093225 | [Sarcoidosis and uveitis : An update] |
Search more.